Paratek Pharmaceuticals Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Private

  • Employees
  • 427

Employees

  • Latest Deal Type
  • Debt - Acquisition

  • Financing Rounds
  • 21

  • Investments
  • 3

Paratek Pharmaceuticals General Information

Description

Developer of antibacterial products intended to treat infectious diseases and improve patient outcomes. The company offers therapies based on advanced tetracycline chemistry, including omadacycline for pneumonia and skin infections, and sarecycline for acne and rosacea, enabling patients with bacterial and inflammatory conditions to achieve better clinical results and improved quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 1000 First Avenue
  • Suite 200
  • King of Prussia, PA 19406
  • United States
+1 (617)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Corporate Office
  • 1000 First Avenue
  • Suite 200
  • King of Prussia, PA 19406
  • United States
+1 (617)

Paratek Pharmaceuticals Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Paratek Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Paratek Pharmaceuticals‘s full profile, request access.

Request a free trial

Paratek Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antibacterial products intended to treat infectious diseases and improve patient outcomes. The company offe
Pharmaceuticals
King of Prussia, PA
427 As of 2026

Melbourne, Australia
 

Melbourne, Australia
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Paratek Pharmaceuticals Competitors (72)

One of Paratek Pharmaceuticals’s 72 competitors is Neuren Pharmaceuticals, a Corporation company based in Melbourne, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neuren Pharmaceuticals Corporation Melbourne, Australia
Mesoblast Corporation Melbourne, Australia
The Zambon Group Private Debt Financed Bresso, Italy
Amyndas Pharmaceuticals Accelerator/Incubator Backed Jackson, WY
Bugworks Research Private Equity-Backed Wilmington, DE
You’re viewing 5 of 72 competitors. Get the full list »

Paratek Pharmaceuticals Patents

Paratek Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021288202-A1 Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof Pending 11-Jun-2020
CA-3179596-A1 Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof Pending 11-Jun-2020
EP-4165016-A1 Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof Pending 11-Jun-2020
EP-4165016-A4 Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof Pending 11-Jun-2020
JP-2026067882-A Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof Pending 11-Jun-2020 C07C231/24
To view Paratek Pharmaceuticals’s complete patent history, request access »

Paratek Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Paratek Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Paratek Pharmaceuticals‘s full profile, request access.

Request a free trial

Paratek Pharmaceuticals Investments & Acquisitions (3)

Paratek Pharmaceuticals’s most recent deal was a Buyout/LBO with Radius Health. The deal was made on 16-Mar-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Radius Health 16-Mar-2026 Buyout/LBO Pharmaceuticals
OptiNose 21-May-2025 Buyout/LBO Drug Delivery
Transcept Pharmaceuticals 30-Oct-2014 Merger/Acquisition Drug Delivery
To view Paratek Pharmaceuticals’s complete investments and acquisitions history, request access »

Paratek Pharmaceuticals Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
OptiNose PA 2010
Radius Health Boston, MA 2003

Paratek Pharmaceuticals FAQs

  • When was Paratek Pharmaceuticals founded?

    Paratek Pharmaceuticals was founded in 1996.

  • Where is Paratek Pharmaceuticals headquartered?

    Paratek Pharmaceuticals is headquartered in King of Prussia, PA.

  • What is the size of Paratek Pharmaceuticals?

    Paratek Pharmaceuticals has 427 total employees.

  • What industry is Paratek Pharmaceuticals in?

    Paratek Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Paratek Pharmaceuticals a private or public company?

    Paratek Pharmaceuticals is a Private company.

  • What is Paratek Pharmaceuticals’s current revenue?

    The current revenue for Paratek Pharmaceuticals is .

  • How much funding has Paratek Pharmaceuticals raised over time?

    Paratek Pharmaceuticals has raised $1.57B.

  • Who are Paratek Pharmaceuticals’s investors?

    REPAIR Impact Fund, B-FLEXION Life Sciences, Novo Holdings, and CBC Group (Singapore) have invested in Paratek Pharmaceuticals.

  • Who are Paratek Pharmaceuticals’s competitors?

    Neuren Pharmaceuticals, Mesoblast, The Zambon Group, Amyndas Pharmaceuticals, and Bugworks Research are some of the 72 competitors of Paratek Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process